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Objectives: the aim of this study was to illustrate how a Bayesian hierarchical modelling approach can aid the reliable
comparison of outcome rates between surgeons.
Design: retrospective analysis of prospective and retrospective data.
Materials: binary outcome data (death/stroke within 30 days), together with information on 15 possible risk factors specific
for CEA were available on 836 CEAs performed by four vascular surgeons from 1992±99. The median patient age was 68
(range 38±86) years and 60% were men.
Methods: the model was developed using the WinBUGS software. After adjusting for patient-level risk factors, a
cross-validatory approach was adopted to identify `` divergent'' performance. A ranking exercise was also carried out.
Results: the overall observed 30-day stroke/death rate was 3.9% (33/836). The model found diabetes, stroke and heart
disease to be significant risk factors. There was no significant difference between the predicted and observed outcome
rates for any surgeon (Bayesian p-value4 0.05). Each surgeon had a median rank of 3 with associated 95% CI 1.0±5.0,
despite the variability of observed stroke/death rate from 2.9±4.4%. After risk adjustment, there was very little residual
between-surgeon variability in outcome rate.
Conclusions: Bayesian hierarchical models can help to accurately quantify the uncertainty associated with surgeons'
performance and rank.
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Introduction
Performance measures for surgeons and units are
increasingly used to introduce professional account-
ability and to set clinical standards.1 Traditionally,
crude outcome rates have been used to compare sur-
gical or hospital performances. However there is little
doubt that true comparisons can only be achieved
after adjustment for case-mix.2±5 Even after such
adjustment, classical `` fixed-effects'' methods emp-
loyed to quantify a surgeon's effect on outcome of
procedures often fail if missing or `` noisy'' data are
encountered. Furthermore, comparing outcome of
surgeons with small caseloads can be a difficult task.6
Several authors have highlighted such metho-
dological concerns with the traditional approach to
performance assessment,7,8 advocating instead the
use of hierarchical or multi-level models in which it
is assumed that the (latent) surgeon-specific effects are
drawn from some common distribution. The theoret-
ical advantages of these models have been known for
a long time9 and they have been widely used in geo-
graphical epidemiology,10,11 educational research,12,13
and more recently, in health performance assess-
ment.7,14±18 Such models in general, and the Bayesian
hierarchical approach19 adopted here, in particular,
allow the appropriate pooling of information across
surgeons to overcome problems of small sample
sizes.16 This pre-empts the need for an arbitrary
decision to be made as to whether there is enough
information (i.e. a surgeon has performed enough
operations) to allow reliable inference to be drawn.
Bayesian hierarchical models also provide a coherent
inference framework that permits the incorporation of
multiple sources of variability ± including that arising
from missing covariate or outcome data.
Early identification of `` divergent'' surgeons14 ±
surgeons whose outcome cannot be assumed to be
drawn from the same distribution as that of their
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peers ± will hopefully prevent incidences similar to
the Bristol heart scandal.20 There is increasing pres-
sure from the media and consumer groups to rank and
produce `` league tables'' of performance of surgeons.
Identifying surgeons who are not divergent yet are
significantly above or below average could provide
the opportunity to inform procedural practice with a
view to improving outcome rates across the board. A
surgeon's rank, however, has an associated uncer-
tainty that must be quantified accurately before infer-
ences regarding relative performances can be made.21
Estimates of this uncertainty can be obtained very
easily as a by-product of the current analysis.
It should be stressed that the methods outlined in
this paper are only appropriate for retrospective
analysis. There is an emerging literature proposing
alternative methodologies for continuous time
medical surveillance.22±26 The aims of the current
study were to illustrate the use of a Bayesian two
level hierarchical model to identify `` divergent'' sur-
geons and to carry out a ranking exercise, which will
enable reliable comparison of surgical performance.
Methods and Analysis
A series of 836 CEAs performed by four vascular
surgeons from two units from 1992 to 1999 were avail-
able for analysis. Data on 67 risk factors were collected
using pre-printed sheets and later entered into a data-
base based on Access 97 (Microsoft, Redmond, U.S.A).
The number of risk factors was reduced to 15 based on
previous studies in the literature and on univariate
analysis27 (Table 1). The outcome endpoints were the
occurrence of major stroke or death within 30 days of
the procedure. Major stroke was defined by any
neurological deficit lasting more than 7 days. One
unit had prospectively collected data (41%) while the
other unit had mixed prospective and retrospective
data (59%). The outcome data were obtained by out-
patient follow up by surgeons and case note review.
Data on deaths occurring outside the hospital were
obtained from the local registry office for deaths.
Median patient age was 68 (range 38±86) years and
60% were men.
A logistic regression model was fitted at the first
level of our model including the risk factors and a
surgeon-specific parameter. These surgeon-specific
parameters reflect the effect of all unmeasured covari-
ates on an individual's risk of death/stroke following
a CEA performed by that particular surgeon. At the
second level of the hierarchy, they were assumed to be
drawn from a common Normal population distribu-
tion. The estimated variance of this distribution was
used to quantify the residual variability in outcome
between surgeons (on a logit scale) after adjustment
for differences in patient case-mix. Since we adopt
a Bayesian approach to inference, the model is com-
pleted through specification of prior distributions for
all the model unknowns. In the absence of strong prior
information, we assume uninformative priors for all
regression coefficients, and the mean and variance of
the Normal random effects distribution.
The regression coefficients and associated 95%
Bayesian Credible Intervals (95% BCI) were computed
via the Gibbs sampler, a Markov chain Monte Carlo
(MCMC) technique,28 which was implemented using
WinBUGS software.29 The exponential of these coeffi-
cients was taken to obtain Odds Ratio (OR) estimates
and their 95% BCI's. Missing covariate data were
imputed at each iteration of the Gibbs sampler and
so the estimates of all parameters were fully adjusted
for this additional associated uncertainty. The 30-day
stroke or death risk for various combination of risk
factors were obtained to identify a high-risk group.
The model was used to ascertain whether any
surgeons could be considered `` divergent''. Following
Spiegelhalter et al.20 we excluded each surgeon in
turn, fitted the model to the data from the remaining
surgeons and then, given the observed case-mix of
his/her patients, predicted the expected death/stroke
rate for the excluded surgeon. The latter was labelled
as divergent if his observed death/stroke rate was
significantly different from that predicted. This com-
parison is summarised by way of the Bayesian prob-
ability, or p-value30 defined here as pprobability that
the predicted rate is less than that observed. This
quantity is computed via MCMC by introducing a
dummy indicator variable for the excluded surgeon
which takes the value 1 at a given iteration if, at that
iteration, the value of his/her predicted mortality rate
is less than or equal to the observed rate, and 0 other-
wise. The mean of the values of this indicator variable
over all iterations yields the required p-value. A prob-
ability close to 1 (say40.95) could be cause for
concern since it indicates that prediction is nearly
always lower than that observed, thus casting doubt
Table 1. Selected risk factors for the model.
Age Respiratory disease





Renal failure Vascular unit
Contralateral internal
carotid artery occlusion
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on the model or, equivalently, suggesting that the
mortality rate for that surgeon is significantly different
from his peers.
The built in rank function in WinBUGS was used to
identify surgeons whose effect is in the extremes of
this distribution. Results presented here were based
on multiple runs of length 10 000 following a burn-in
of 1000 iterations to achieve convergence.31
Results
Observed stroke or death rate was 3.9% (33/836).
The prevalence of missing data for each variable is
given in Table 2. Intra operative shunt was used in
60% (501/839) and 61% (513/839) were repaired using
a patch. Diabetes (OR 2.65, 95% BCI (1.1, 6.2)), heart
disease (OR 2.23, 95% BCI (1.04, 4.73)) and previous
stroke (OR 3.13, 95% BCI (1.54, 7.12)) were the sig-
nificant risk factors identified by the model. This
agrees with the results from earlier modelling using
backward elimination on SPSS at a 5% significance
level.27 The median risk of 30-day stroke or death for
the 3 risk factors and the various combinations are
shown in Table 3. An individual in the highest risk
group (presence of all 3 risk factors) had a median
stroke or death risk of 12.7% (3.2, 36.6) compared to
the 0.6% (0.14, 1.60) of an individual presenting with
none of the three major risk factors.
The observed 30-day stroke or death risk varied
from 2.9±4.4% for the four vascular surgeons. The
caseloads were also variable from 102 to 383. There
was no significant difference between the observed
and the predicted 30-day stroke or death risk for any
of the surgeons (Table 4). No surgeon was labelled
divergent and an assumption of a common distri-
bution of surgeon effects seemed appropriate. Focuss-
ing now on this distribution, there was little variability
in outcome after adjustment for significant risk factors
between the four surgeons studied (Fig. 1). This
variability can be quantified on a more interpretable
scale by considering a patient's risk of death/stroke if
operated on by a `` high-risk'' surgeon compared to a
`` low-risk'' surgeon (OR 1.3 95% BCI (1.05, 4.93)).
A high-risk surgeon is defined as one whose surgeon-
specific effect lies in the upper tail (mean  1 s.d.) of
the random effects distribution, whereas a low-risk
surgeon's effect lies in the lower tail (mean ÿ1 s.d.).
The median rank for all surgeons was 3.0 with
associated 95% BCI of 1.0±5.0.
Discussion
Since the introduction of clinical governance there has
been greater emphasis to introduce performance
measures for surgeons and units. Case-mix adjusted
outcome rates are needed for accurate comparison
of surgical performance. Comparison of median pre-
dicted rates after risk adjustment with the observed
outcome rates indicate surgeons 2 and 4 to have
higher mortality rate than that expected. However
the 95% credible intervals and the Bayesian p-values
show that none of the predicted outcome was signifi-
cantly different from the observed (Table 4). That is,
there were no divergent performers amongst the
population of surgeons in this study. Due to the high
level of variability associated with the estimates of
surgical performance, the estimated rank for each
surgeon had huge associated credible intervals cover-
ing the whole range (Fig. 1). This indicates how league
tables, which do not consider risk adjustment for
patient-level factors and do not account for random
variation, should be interpreted with caution. In a
previous study a simpler fixed-effects logistic regres-
sion model was implemented to compare the
surgeons performance and the difference in the out-
comes after risk adjustment was not found to be stat-
istically significant.27 Comparison of this model to the
more complex Bayesian two level hierarchical model
is made throughout the course of the discussion.
The current model identified diabetes, heart disease
and previous stroke to be significant risk factors for
30-day stroke or death following CEA. Diabetes is a
well-known risk factor for stroke and myocardial
Table 2. Prevalence of missing data for each risk factor.
Risk factor (%) missing Risk factor (%) missing
Age 0 (0/836) Contralateral ICA 9.5 (80/836)
Sex 0 (0/836) Respiratory disease 0.2 (2/836)
Hypertension 0.8 (8/836) Side of operation 0.2 (2/836)
Heart disease 0.9 (8/836) Shunt 1.6 (14/836)
Diabetes 0.2 (2/836) Patch 1.3 (11/836)
Stroke 0.2 (2/836) Renal failure 0.8 (7/836)
Table 3. Thirty day stroke or death rates for each risk factors.





None 0.60 (0.14, 1.60)
Stroke 1.11 (0.27, 3.76)
Diabetes 1.31 (0.28, 5.23)
Heart disease 1.58 (0.47, 4.54)
Diabetes and stroke 2.87 (0.64, 10.91)
Stroke and heart disease 3.42 (0.94, 10.6)
Diabetes and heart disease 5.38 (1.01, 15.10)
Diabetes, stroke and heart disease 12.71 (3.2, 36.60)
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infarction.32 In the North American Symptomatic
Carotid Endarterectomy Trial diabetes was associated
with a two-fold increase in the risk of peri-operative
stroke or death.33 Similarly pre existing heart disease
and stroke are associated with an increased operative
risk of stroke or death.34,35 As expected, the same three
risk factors emerged as significant in the classical
approach.27 As with the latter, the current model
allowed estimation of risk of stroke or death for the
various combinations of risk factors, which can be
used to counsel patients before the operation (Table 3).
In the traditional approach the surgeon specific
variables were introduced as fixed effects into the
developed risk model. Odds ratios for each surgeon,
relative to a designated reference, were then calcu-
lated based only on the data specific to that surgeon.
Adopting this approach, a surgeon who performed
few operations is more likely to have an extreme
odds ratio due to chance alone. In contrast, the
hierarchical model pools data across all surgeons to
calculate the odds ratios and confidence limits thus
making comparative audit more robust, and in our
opinion, more reliable. In general, estimates based on
large patient populations are preserved yet those
based on sparse data are shrunk towards the
population average. There is the danger of `` over-
shrinking'' and potentially masking true, but low-
volume, outliers. However, given the potential
consequences of declaring a surgeon to be an outlier,
we advocate the current, more conservative approach.
One of the aims of the current study was to illus-
trate how a hierarchical modelling approach allows
the reliable estimation of the uncertainty associated
with a surgeon's effect on outcome. The observed
outcome rates varied from 2.9 to 4.4% for the four
surgeons (Table 4). After risk adjustment, however,
there was very little residual variability in the risk of
death between surgeons. What variability there was
could be attributed to differences in surgical perform-
ance but could equally be reflecting systematic yet
unmeasured differences in patient case-mix. There
will always be variability in outcome and one could
argue that an aim of comparative audit should be to
try and identify the cause of this variability through
sensitive investigation.
Missing data are a major source of bias. Missing
data however are inevitable in routinely collected
administrative data and reflect the quality of data
collection. In the current study the missing data was
1.4% for the selected variables. Contra lateral internal
carotid disease had the highest percentage of missing
data (9.5%). In the traditional analysis27 98 procedures
were excluded due to missing data items. Many critics
argue that 98 CEAs reflects approximately one to
two years of workload in most vascular units and
measures should be taken to incorporate that data. In
the current study none of the missing data were
excluded. Missing data was imputed at each iteration
of the Gibbs sampler the additional source of uncer-
tainty acknowledged in all estimates. Although we
assume in the current paper, that those data were
missing at random, the flexibility of the Bayesian
approach is such that informative missing data
mechanisms may easily be modelled.36
There were shortcomings as well as strengths in the
methods employed in the current paper. The current
model was developed on routinely collected data
which may not be perfect.14 After risk adjustment it
was assumed the residual variability could be
assigned to differences in surgical performance
although like many performance assessment methods,
ours is open to the criticism of insufficient case-mix













to be less than
observed
1 237 4.2 4.7 (0.4, 12.6) 0.5612
2 114 4.4 4.1 (0.0, 9.6) 0.7011
3 102 2.9 4.0 (0.0, 9.8) 0.4712
4 383 3.9 2.3 (0.2, 5.7) 0.9180
















Fig. 1. Mean rank and 95% intervals for each surgeon.
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adjustment. The same risk factors of 30-day mortality
were identified under both the Classical and Bayesian
approaches and both analyses led to a conclusion of
no difference in performance between the surgeons.27
The advantage of the approach taken in this study is
that outcome data from all surgeons can be incorpo-
rated in one coherent inference framework, including
those with missing covariate information or low case-
load. The Bayesian approach avoids the need for
arbitrary decision making a priori regarding the suffi-
ciency (or not) of the information relating to a particu-
lar surgeon. We are also able to quantify both the
variability in the surgeons' ranks and that in outcome
between surgeons, after adjusting for major patient-
specific risk factors. Advances in computing have
meant that the MCMC methods are now increasingly
used to tackle wide variety of problems in statistics.
The current model could easily be extended to a third
level to compare performances between vascular units
after adjustment for patient and surgeon characteris-
tics, or used for the comparative audit of other index
procedures in vascular surgery.
Implications of identifying performance divergence
will raise great concern for the patients and the sur-
geon involved. However it should be emphasised that
risk models are tools for comparative audit and
should not be applied blindly. Surgical competency
should also be judged at a clinical level and not purely
on outcome measures. Furthermore, identifying sur-
geon-effects to be in the tails of their distribution is not
necessarily cause for alarm ± as Poloneicki37 points
out, half of all surgeons will be below average. None-
theless, this information could provide valuable feed-
back to improve practice.
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